Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,629,874
  • Shares Outstanding, K 164,510
  • Annual Sales, $ 3,094 M
  • Annual Income, $ 173,000 K
  • 60-Month Beta 1.58
  • Price/Sales 4.86
  • Price/Cash Flow 24.41
  • Price/Book 4.89
Trade CTLT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.33
  • Number of Estimates 5
  • High Estimate 0.49
  • Low Estimate 0.26
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +94.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.88 +7.30%
on 10/02/20
96.38 -7.73%
on 10/13/20
+4.82 (+5.73%)
since 09/28/20
3-Month
79.65 +11.65%
on 09/25/20
96.38 -7.73%
on 10/13/20
+8.25 (+10.23%)
since 07/28/20
52-Week
31.04 +186.50%
on 03/18/20
96.38 -7.73%
on 10/13/20
+38.81 (+77.43%)
since 10/28/19

Most Recent Stories

More News
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates

United Therapeutics' (UTHR) third-quarter earnings and sales beat estimates. Higher sales of Orenitram and Tyvaso offset lower sales of Remodulin and Adcirca.

MDT : 102.59 (-2.49%)
LLY : 131.31 (-0.45%)
UTHR : 132.03 (+6.99%)
CTLT : 88.93 (-2.80%)
Catalent und BrainStorm Cell Therapeutics geben Partnerschaft zur Herstellung von NurOwn(R), einer auf mesenchymalen Stammzellen beruhenden Therapie, bekannt

SOMERSET, N.J. und NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Catalent (NYSE: CTLT), der weltweit fuhrende Anbieter von modernen Verabreichungstechnologien, Entwicklungs- und Fertigungslosungen fur...

CTLT : 88.93 (-2.80%)
BCLI : 10.08 (-4.55%)
Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn(R)

SOMERSET, N.J. and NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...

CTLT : 88.93 (-2.80%)
BCLI : 10.08 (-4.55%)
Catalent, Inc. Announces First Quarter Fiscal Year 2021 Earnings Conference Webcast

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

CTLT : 88.93 (-2.80%)
Catalent Inc Falls 2.98% on Heavy Volume: Watch For Potential Rebound

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $92.05 to a high of $95.20. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $93.06...

CTLT : 88.93 (-2.80%)
AcelRx (ACRX) Looks Good: Stock Adds 5.3% in Session

AcelRx (ACRX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

ACRX : 1.7800 (+1.71%)
CTLT : 88.93 (-2.80%)
Akebia Therapeutics (AKBA) Looks Good: Stock Adds 6.7% in Session

Akebia Therapeutics (AKBA) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

AKBA : 2.34 (-3.31%)
CTLT : 88.93 (-2.80%)
After Yesterday's Rally of 1.67% Shares Could Potentially Pullback

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $91.50 to a high of $93.06. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $91.84...

CTLT : 88.93 (-2.80%)
Ironwood to End IW-3718 Development After Study Failure

Ironwood's (IRWD) pipeline candidate, IW-3718, fails to meet primary endpoint in a phase III study evaluating it in patients with refractory GERD.

IRWD : 9.50 (-1.04%)
AZN : 50.98 (-2.86%)
ABBV : 80.49 (-2.68%)
CTLT : 88.93 (-2.80%)
Endo (ENDP) Surges: Stock Moves 8.4% Higher

Endo (ENDP) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ENDP : 5.06 (-7.50%)
CTLT : 88.93 (-2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the...

See More

Key Turning Points

2nd Resistance Point 91.30
1st Resistance Point 90.11
Last Price 88.93
1st Support Level 88.22
2nd Support Level 87.52

See More

52-Week High 96.38
Last Price 88.93
Fibonacci 61.8% 71.42
Fibonacci 50% 63.71
Fibonacci 38.2% 56.00
52-Week Low 31.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar